Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04597359
What this trial is testing

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Who this might be right for
Prostate Carcinoma
ECOG-ACRIN Cancer Research Group 360
Testing effectiveness (Phase 2)WithdrawnNCT01138579
What this trial is testing

Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation

Who this might be right for
LeukemiaStem Cell Transplantation
Technical University of Munich
Early research (Phase 1)Study completedNCT03875079
What this trial is testing

Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Hoffmann-La Roche 83
Not applicableStudy completedNCT00107679
What this trial is testing

Anal Cancer Development in HIV Infected People

Who this might be right for
HIV InfectionsAnus Neoplasms
National Institute of Allergy and Infectious Diseases (NIAID) 560
Not applicableLooking for participantsNCT06327178
What this trial is testing

Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.

Who this might be right for
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC
Nanfang Hospital, Southern Medical University 20
Early research (Phase 1)Study completedNCT00001512
What this trial is testing

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Who this might be right for
B Cell LymphomaFollicular LymphomaLymphoma
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT05147844
What this trial is testing

Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing 40
Testing effectiveness (Phase 2)Ended earlyNCT05588609
What this trial is testing

Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers

Who this might be right for
NSCLC Harboring NRG1 FusionMetastatic Castration-resistant Prostate Cancer
Partner Therapeutics, Inc. 13
Not applicableUnknownNCT05572099
What this trial is testing

ExoDx Prostate Evaluation in Active Surveillance Patient Population

Who this might be right for
Prostate Cancer
Exosome Diagnostics, Inc. 750
Early research (Phase 1)Looking for participantsNCT07252414
What this trial is testing

GenSci143 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd. 180
Testing effectiveness (Phase 2)Ended earlyNCT04009681
What this trial is testing

A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)

Who this might be right for
Metastasis
Synthorx, Inc, a Sanofi company 175
Not applicableStudy completedNCT04396665
What this trial is testing

Breast Cancer: Feasibility of an Educational Intervention

Who this might be right for
Women's Health: Neoplasm of Breast
University of Oviedo 224
Testing effectiveness (Phase 2)UnknownNCT04488107
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

Who this might be right for
Breast Neoplasms
Ahon Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT05173792
What this trial is testing

Study of AK119 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Akeso 16
Early research (Phase 1)Study completedNCT06219902
What this trial is testing

Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 64
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Early research (Phase 1)Looking for participantsNCT06402201
What this trial is testing

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

Who this might be right for
Select Advanced Solid Tumors
CDR-Life AG 42
Not applicableStudy completedNCT00327236
What this trial is testing

The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes

Who this might be right for
Paraneoplastic Syndromes
Rockefeller University 109
Not applicableLooking for participantsNCT06550687
What this trial is testing

Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.

Who this might be right for
All Types of Metastatic Solid Malignancy1st-line TreatmentExome Analysis+1 more
Centre Georges Francois Leclerc 80
Testing effectiveness (Phase 2)Study completedNCT04294498
What this trial is testing

Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection

Who this might be right for
Advanced Hepatocellular Carcinoma
National Taiwan University Hospital 30
Next Page